March 2006



James Joye, DO

Dr. James Joye, inventor of cryoplasty, discusses his experiences developing the procedure, bias in medicine, and the latest initiatives of VIVA Physicians.

By James Joye, DO


Highlights From ISET

Nonstent Endovascular Treatment of SFA Occlusions

High failure rates of balloon angioplasty and stent fracture suggest a need for nonstent alternatives.

By Robert S. Dieter, MD, RVT, and John R. Laird, Jr, MD

Direct Tibial Artery Access: A New Approach to Challenging CTOs

When conventional femoral access did not permit antegrade guidewire traversal, successful retrograde guidewire traversal was achieved in four cases using direct tibial artery puncture.

By Shaddy K. Younan, MD, and David E. Cohen, MD


Crossing Peripheral CTOs

A look at today’s options, from guidewires to re-entry devices.

By Tony Das, MD

Successful CTO Recanalization

A case-based review of new tools and techniques.

By James Joye, DO

When Is Surgery Still the Best Option?

Given the variety of endovascular treatment modalities for lower-leg interventions, when should physicians consider surgical treatment in their patient management?

By Panagiotis Kougias, MD; Wei Zhou, MD; Alan B. Lumsden, MD; and Peter H. Lin, MD

Creative Access Techniques for CTOs

New technology and unconventional approaches help to maximize success in difficult cases.

By Charles F. Botti, Jr, MD, and Gary M. Ansel, MD

Thrombolytic Therapy for Peripheral CTOs

The role of this therapy has expanded, allowing for successful treatment of more patient groups.

By Amir Motarjeme, MD


MR Safety of Cardiovascular Implants

New standards are being developed to ensure patient safety during procedures involving magnetic resonance imaging.

By Terry O. Woods, PhD


An Overview of the CTO Device Market

As the number of lower-limb PAD treatments increases, the market for CTO crossing aids to permit these treatments will develop, driving this market to $355 million by 2011.

By Kamran Zamanian, PhD


Chronic Total Occlusions

By John R. Laird, Jr, MD Chief Medical Editor


Options for Treating the Saphenous Vein

A discussion of radiofrequency versus laser versus chemical ablation.

By Jose I. Almeida, MD, FACS, RVT, and Jeffrey K. Raines, PhD, RVT

Saphenous Vein Ablation

Do different laser wavelengths translate into different patient experiences?

By Edward G. Mackay, MD; Jose I. Almeida, MD; and Jeffrey K. Raines, PhD


Recent Milestones and Future Goals of the SIR

As it gears up for its 2006 annual meeting, the Society of Interventional Radiology continues working to advance quality patient care.

By Curtis A. Lewis, MD, MBA

Contact Info

For advertising rates and opportunities, contact:
Craig McChesney

Stephen Hoerst

Charles Philip

About Endovascular Today

Endovascular Today is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the endovascular field. Our Editorial Advisory Board is composed of the top endovascular specialists, including interventional cardiologists, interventional radiologists, vascular surgeons, neurologists, and vascular medicine practitioners, and our publication is read by an audience of more than 22,000 members of the endovascular community.